Chang et al (November 1999) 1 studied the usefulness of four health-related quality of life (QOL) instruments, two generic and two respiratory-specific measures, in a group of interstitial lung disease patients (33 idiopathic pulmonary fibrosis [IPF], 10 sarcoidosis, and 7 miscellaneous), and concluded that the Medical Outcome Study Short Form 36 (SF-36) and the St. George's Respiratory Questionnaire (SGRQ) are good tools for measuring health-related QOL or health status.
To the Editor:
We appreciate the concerns expressed by Drs. De Vries and Drent about our recent publication in CHEST. 1 We agree whole-heartedly with the importance of distinguishing quality of life from health-related quality of life and health status. This is an important distinction and a distinction that one of us has written about extensively. 2 Our article assesses health-related quality-oflife measures, and Drs. De Vries and Drent correctly point out that, in a few places in the article, 1 we abbreviated the concept as quality of life when we should have used the abbreviation HRQOL (for health-related quality of life). Drs. De Vries and Drent cite some potentially exciting qualitative work comparing the Saint Georges Respiratory Questionnaire (SGRQ) and the World Health Organization Quality of Life (WHOQOL) instrument. We look forward to seeing this research in print. However, in choosing between the SGRQ, the Medical Outcomes Study Short Form-36, and the WHOQOL, it will be important that researchers decide what domains are most important in the particular study: quality of life or health-related quality of life and generic or disease-specific. Furthermore, for studies in which both domains are important, it will be important to have headto-head comparisons of the instruments measuring the reliability, validity, and responsiveness of each. It will not be possible to make the blanket statement that WHQOL or SGRQ is a better measure for sarcoidosis or idiopathic pulmonary fibrosis based on a single qualitative study.
